THE Medical Journal of Australia
has released an article highlighting
concerns about therapeutic drug
safety for Indigenous Australians.
It notes that drug development
programs often don’t include
Indigenous Australians and few
randomised control trials have
been performed in this population.
“Attention is given to reporting
the safety of medications in older
people and paediatric populations,
and in pregnant and breastfeeding
women. However, in Australia,
there are no specific reporting
requirements for ethnic groups,
including Aboriginals and Torres
Strait Islanders,” says the article.
It concludes that the lack of a
robust evidence base means “the
potential for harm is real.”The above article was sent to subscribers in Pharmacy Daily's issue from 19 Jan 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Jan 16
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.